Tenure-track Faculty Position in Chemical Biology
Genomics Research Center, Academia Sinica
Posted Date: 2025-09-10
Title: Tenure-track faculty position in chemical biology: 1 Person
Work Content:
- Develop innovative approaches in chemical biology for disease-related research.
- Design or identify bioactive molecules and metabolites, informed by metabolomics.
- Apply synthetic or AI-assisted drug design strategies for diagnostics and therapeutics.
- Collaborate across disciplines, publish, and mentor students and trainees.
Qualification:
- Ph.D. (or equivalent) in chemical biology, chemistry, biochemistry, or related fields with postdoctoral training.
- Research expertise in probe chemistry, bioactive molecules, or drug discovery.
- Experience with AI-assisted drug design is an advantage.
- Evidence of research excellence through publications and funding potential.
- Independent, collaborative, and proficient in English (Chinese not required).
Salary:
Salary to be commensurate with experience.
Required Documents:
- Cover letter (background, experience, a brief statement of research direction, and contact information for three referees)
- Curriculum vitae (education; positions; major achievements; funding record, if any; publications and patents list)
- Statement of research accomplishments and future plans
- Names and contact information of three references. Please arrange for recommendation letters to be sent directly by the letter writers to the Search Committee.
Place:
128 Academia Road, Section 2, Nankang, Taipei 11529 Taiwan
Genomics Research Center, Academia Sinica
Remark:
Please combine all materials into a single PDF and email the file to the Chair of the Faculty Search Committee, Dr. Yun-Ru (Ruby) Chen, c/o Ms. Susan Tsai (email: susantsa@as.edu.tw). Review of applications will begin in late December 2025 and continue until the position is filled.
Website:
https://www.genomics.sinica.edu.tw/?locale=en
Contact / Telephone or E-mail:
Ms. Susan Tsai
E-mail: [susantsa@as.edu.tw](mailto:susantsa@as.edu.tw)
Deadline:
12-31-2025